Evidence map›Paper›PMID 29683998›Full record

ReviewTransplantation2018

Diagnosis, Pathophysiology and Experimental Models of Chronic Lung Allograft Rejection.

Jason M Gauthier, Daniel Ruiz-Pérez, Wenjun Li, Ramsey R Hachem, Varun Puri, Andrew E Gelman, Daniel Kreisel

Abstract readReview
In one paragraph

Review in Transplantation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Cellular and Molecular Aspects of Chronic Rejection.Results and problems in cell differentiation · 2026
    Review
  4. Blood vessels as primary site of rejection in murine lung transplantation.Transplant international : official journal of the European Society for Organ Transplantation · 2026
    Article
  5. Review
  6. Review
  7. Animal models for transplant immunology: bridging bench to bedside.Clinical transplantation and research · 2024
    Review
  8. Article
  9. Article
  10. Immune processes in the pathogenesis of chronic lung allograft dysfunction: identifying the missing pieces of the puzzle.European respiratory review : an official journal of the European Respiratory Society · 2022
    Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jason M GauthierDivision of Cardiothoracic Surgery, Department of Surgery.
Daniel Ruiz-PérezDivision of Cardiothoracic Surgery, Department of Surgery.
Wenjun LiDivision of Cardiothoracic Surgery, Department of Surgery.
Ramsey R HachemDivision of Pulmonary and Critical Care Medicine, Department of Medicine.
Varun PuriDivision of Cardiothoracic Surgery, Department of Surgery.
Andrew E GelmanDivision of Cardiothoracic Surgery, Department of Surgery.
Daniel KreiselDivision of Cardiothoracic Surgery, Department of Surgery.

Funding

The Role of Neutrophils in Regulating Lung Transplant ToleranceP01AI116501 · NIAID · WASHINGTON UNIVERSITY · PI Daniel Kreisel · 2015 to 2026
$19.4M
THE ROLE OF ISCHEMIA REPERFUSION INJURY IN LUNG ALLOGRAFT REJECTIONR01HL094601 · NHLBI · WASHINGTON UNIVERSITY · PI Andrew Eric Gelman, Daniel Kreisel · 2009 to 2026
$6.9M
BASIC SCIENCE RESEARCH TRAINING: CARDIOPULMONARY SURGERYT32HL007776 · NHLBI · WASHINGTON UNIVERSITY · PI DAMIANO, RALPH J · 1994 to 2020
$4.6M
Leukocyte trafficking in thoracic graftsI01BX002730 · VA · ST. LOUIS VA MEDICAL CENTER · PI KREISEL, DANIEL · 2016 to 2025
–
BLRD VA I01 BX002730NHLBI NIH HHS R01 HL094601NIAID NIH HHS P01 AI116501
6 · The paper itself

Abstract

Chronic rejection is the Achilles heel of modern lung transplantation, characterized by a slow, progressive decline in allograft function. Clinically, this manifests as obstructive disease, restrictive disease, or a mixture of the 2 depending on the underlying pathology. The 2 major phenotypes of chronic rejection include bronchiolitis obliterans syndrome and restrictive allograft syndrome. The last decade of research has revealed that each of these phenotypes has a unique underlying pathophysiology which may require a distinct treatment regimen for optimal control. Insights into the intricate alloimmune pathways contributing to chronic rejection have been gained from both large and small animal models, suggesting directions for future research. In this review, we explore the pathological hallmarks of chronic rejection, recent insights gained from both clinical and basic science research, and the current state of animal models of chronic lung rejection.

Indexed as

AllograftsAnimalsBronchiolitis ObliteransChronic DiseaseDisease Models, AnimalGraft RejectionGraft SurvivalImmunosuppressive AgentsLung TransplantationRisk FactorsSyndromeImmunosuppressive Agents

Identifiers

PMID29683998
PMCPMC6884147

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.